Michael Aaron Kelly - Insider Trading & Ownership

Location
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, NY
Summary
The estimated net worth of Michael Aaron Kelly is at least $1.72M dollars as of August 5, 2025. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $785K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $450K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $410K. Michael Aaron Kelly is the Director of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $60K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
Signature
/s/ Ryan Brown, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Michael Aaron Kelly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NEO NEOGENOMICS INC Director $785K +$38K +5.09% Jun 1, 2025
FOLD AMICUS THERAPEUTICS, INC. Director $450K Jun 5, 2025
BOOM DMC Global Inc. Director $410K May 14, 2025
HOOK HOOKIPA Pharma Inc. Director $60K Jun 30, 2022
APRE Aprea Therapeutics, Inc. Director $17K Jun 30, 2021
PRME Prime Medicine, Inc. Director Aug 1, 2025

Insider Transactions Reported by Michael Aaron Kelly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.